The Longwood Team is a closely knit group of investor-entrepreneurs that collectively have decades of experience investing, operating, advising, and building some of the most important global biotech companies.
Our work has supported dozens of therapies for patients and defined new categories of medicine. We specialize in both company creation and investing – two synergistic activities that give companies the confidence that we have navigated what they’re facing and give investors the confidence that we can pick winning teams and identify breakthrough, yet achievable, technology with the potential to change lives.
Over the past 25 years, the Longwood team has launched some of the most impactful companies in the life sciences industry. At the heart of Longwood’s company creation approach is:
Innovation: Longwood launches companies with cutting edge technologies sourced from pharma or leading academic institutions.
Newleos Therapeutics is a clinical-stage biotechnology company co-founded by
Progentos is developing a new class of medicines designed
Through passionate pursuit of excellence in medicine, addressing the
Longwood invests in private, early stage biotech companies driving towards clinical proof of concept.
Our portfolio companies pursue differentiated therapeutic products, leveraging highly innovative science, for the treatment of patients suffering from severe and debilitating diseases. We invest from seed through crossover rounds out of dedicated early- and growth-stage funds, working as close partners with our management teams and co-investors.
Longwood's portfolio companies are developing important therapies for unmet medical needs.
Our deep network of leading academic and industry executives helps generate some of the most promising healthcare deals led by top entrepreneurs.
At Longwood, our team finds strength in our diverse backgrounds and passion for innovation.
We’re a team of doctors, investors, entrepreneurs, scientists, and life-long students who are committed to discovering and building science-based companies that are working to change the world.
Longwood Healthcare Leaders hosts thought leaders, leading BioPharma CEOs, heads of Research and Development, renowned academics, and key government officials for off-the-record discussion and networking forums.
These invitation-only meetings aim to foster collaboration, exchange insights, and drive biomedical advancements from the top – facilitating discussions that promote transparency and collaboration among participants with the goal of accelerating the translation of discoveries into medicines that can improve patient outcomes.
